Oncorus raises $80M for 2-front oncolytic virus R&D push
Oncorus has raised $79.5 million to advance oncolytic viruses. The series B round equips Oncorus to move its lead prospect into the clinic and nominate an intravenously administered viral candidate early next year.
That second, intravenous candidate will move the oncolytic virus sector into unchartered territory by...
Optic Nerve Stimulation Device Could Provide Visual Aid for Blind People
Researchers at Ecole Polytechnique Fédérale de Lausanne in Switzerland have developed a new type of intraneural electrode to bypass the eyeball and send messages directly to the brain through the optic nerve. The technique could provide a visual aid for permanently blind people.